| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-2944(74)90046-5 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0006294474900465?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0006294474900465?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 4822034 |
| P50 | author | Stanley Fahn | Q66937460 |
| P2093 | author name string | A. L. Prasad | |
| P2860 | cites work | Pharmacological Reviews | Q2085079 |
| Treatment of Parkinsonism With Levodopa | Q34240368 | ||
| Some observations on the estimation of 3-methoxytyramine in brain tissue | Q39986333 | ||
| Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog. | Q43246560 | ||
| Dopa and 3-O-methyldopa in cerebrospinal fluid of parkinsonism patients during treatment with oral l-dopa | Q43960248 | ||
| Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease | Q44496744 | ||
| A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain | Q44836173 | ||
| Modification of Parkinsonism--chronic treatment with L-dopa | Q45300970 | ||
| Effect of L-DOPA on brain monoamines and their metabolites in Parkinson's disease | Q48824446 | ||
| Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10 | Q48838957 | ||
| Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor | Q51107835 | ||
| Biochemical investigations in patients with Parkinson's disease treated with L-dopa | Q51108402 | ||
| l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions | Q51121102 | ||
| On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method. | Q51285345 | ||
| Catecholamine Metabolism During Oral Administration of Levodopa | Q64916173 | ||
| A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients | Q64916197 | ||
| Serial determinations of homovanillinic acid in the cerebrospinal fluid of Parkinson patients treated with L-dopa. | Q67207400 | ||
| Newer Medical Treatments in Parkinsonism | Q67209364 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| automation | Q184199 | ||
| levodopa | Q300989 | ||
| P304 | page(s) | 136-147 | |
| P577 | publication date | 1974-02-01 | |
| P1433 | published in | Biochemical medicine | Q27709291 |
| P1476 | title | 3-O-methyl metabolites of catecholamines: Automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopa | |
| P478 | volume | 9 |
| Q64865091 | Q64865091 |
| Q41457815 | Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa |
| Q41743797 | Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms |
| Q71463861 | Conjugated HVA increase in rat urine after insulin-induced hypoglycemia: involvement of central dopaminergic structures but not of adrenal medulla |
| Q70900824 | l-DOPA (l-3,4-dihydroxyphenylalanine) uptake by human red blood cells |
Search more.